Ergomed Investor Relations Material
Latest events
H2 2022
Ergomed
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Ergomed plc
Access all reports
Ergomed plc, operates as a clinical research service provider for pharmaceutical and biotechnology companies internationally. The company offers services at all stages of the clinical development process, from study feasibility to final data analysis and reporting. It also provides various resources and services that support the conduct of clinical trials, including patient recruitment, monitoring support, data management, training services, analytical laboratory studies in toxicology, pharmacokinetics/pharmacodynamics (PK/PD), clinical trial material manufacturing (CTM), pharmacovigilance and medical information services. In addition, the company provides certain services to the non-interventional post-marketing phase of drug development; and in support of over-the-counter (OTC) products.
Latest articles
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
ERGO
Country
π¬π§ United Kingdom